Dear Colleague:
I am pleased to provide you with the final agenda for the Pharmaceutical Strategy Series’ Second Annual Global R&D Congress: The Premier Event for Discovery and Development Operations in Emerging Regions. This event brings together the experts and delegates from our industry-recognized annual China and India conferences, as well as those involved in projects in Greater Asia, Russia, and Latin America.
The 2008 Global R&D Congress will be a two-day interacti ve forum of in-depth case studies, roundtable and panel discussions, keynote presentati ons, and break-out sessions by function area. The focus will be on specific strategies and approaches to navigating the opportunities and challenges of drug discovery and development in emerging regions.
Key Take Aways:
- UNDERSTAND IP barriers and trends when planning a global strategy in India, China and other markets
- IMPLEMENT best approaches to outsourcing, in-licensing, out-licensing and risk sharing partnerships
- EXAMINE the regulatory landscape of Asia, Eastern Europe and Latin America
- CLARIFY the business, regulatory and research environment for drug discovery, drug development and clinical research
- MANAGE complicated and long-distance collaborative third-party relationships
- OVERCOME the logistical challenges of transferring technology, data, and staff
- FIND the best discovery and development services and partners
Please review our agenda, and I think you’ll agree this is one event not to miss!
I hope to see you on May 29-30, 2008 at the Ritz-Carlton in Washington, D.C.
Sincerely,
Micah Lieberman
Conference Director
Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute
P.S. Register by March 7, 2008 and Save up to $400!